Three Asian MD Anderson scientists purged in wake of NIH-directed investigations on data violations

In the first public instance of a US biomedical institution sanctioning its own researchers for alleged threats of foreign influence, MD Anderson Cancer Cancer Center is ousting three scientists it says who have violated conflict of interest policies.

The prestigious Houston research hospital has initiated the termination processes in response to NIH letters requesting that it look into the conduct of specific researchers. The actions also follow some ongoing engagement with the FBI that dated back at least two years, according to the Houston Chronicle and Science, which first reported the news.

In order to read this article, you must be an Endpoints News subscriber. (It's free to subscribe.)

← Go back

We produce two daily email newsletters designed to give you a complete picture of what's important in biopharma. It's free to subscribe and never any spam. Join 51,200+ biopharma executives who read Endpoints News every day.

Access is subject to the terms in our Privacy Policy.

The best place to read Endpoints News? In your inbox.

Comprehensive daily news report for those who discover, develop, and market drugs. Join 51,200+ biopharma pros who read Endpoints News by email every day.

Free Subscription

VP Oncology Biology
Skyhawk Therapeutics Waltham, MA
Associate Director CMC
Elektroki Boston, MA
Director Process Development
Elektroki Boston, MA
Research Scientist - Immunology
Recursion Pharmaceuticals Salt Lake City, UT

Visit Endpoints Careers ->